0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Morquio Syndrome Treatment Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-34H5635
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Morquio Syndrome Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Morquio Syndrome Treatment Market Research Report 2024

Code: QYRE-Auto-34H5635
Report
May 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Morquio Syndrome Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Morquio Syndrome Treatment Market

Morquio Syndrome Treatment Market

Morquio syndrome is a type of mucopolysaccharide metabolic disorder, that is, type Ⅳ in mucopolysaccharide storage disease, also known as hereditary cartilage dystrophy syndrome
The global Morquio Syndrome Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Morquio Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Morquio Syndrome Treatment.

Report Scope

The Morquio Syndrome Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Morquio Syndrome Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Morquio Syndrome Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Morquio Syndrome Treatment Market Report

Report Metric Details
Report Name Morquio Syndrome Treatment Market
CAGR 5%
Segment by Type
  • Morquio A
  • Morquio B
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioMarin, Genzyme Corporation,, Shire, JCR Pharmaceuticals, Sanofi, Sangamo Therapeutics, Green Cross, Concert Pharmaceuticals, Alexion Pharmaceuticals, Roche, Pfizer, Lupin, Cambrex Corporation, Cipla, Bayer, Daiichi Sankyo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Morquio Syndrome Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Morquio Syndrome Treatment Market report?

Ans: The main players in the Morquio Syndrome Treatment Market are BioMarin, Genzyme Corporation,, Shire, JCR Pharmaceuticals, Sanofi, Sangamo Therapeutics, Green Cross, Concert Pharmaceuticals, Alexion Pharmaceuticals, Roche, Pfizer, Lupin, Cambrex Corporation, Cipla, Bayer, Daiichi Sankyo

What are the Application segmentation covered in the Morquio Syndrome Treatment Market report?

Ans: The Applications covered in the Morquio Syndrome Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Morquio Syndrome Treatment Market report?

Ans: The Types covered in the Morquio Syndrome Treatment Market report are Morquio A, Morquio B

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Morquio Syndrome Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Morquio A
1.2.3 Morquio B
1.3 Market by Application
1.3.1 Global Morquio Syndrome Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Morquio Syndrome Treatment Market Perspective (2019-2030)
2.2 Morquio Syndrome Treatment Growth Trends by Region
2.2.1 Global Morquio Syndrome Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Morquio Syndrome Treatment Historic Market Size by Region (2019-2024)
2.2.3 Morquio Syndrome Treatment Forecasted Market Size by Region (2025-2030)
2.3 Morquio Syndrome Treatment Market Dynamics
2.3.1 Morquio Syndrome Treatment Industry Trends
2.3.2 Morquio Syndrome Treatment Market Drivers
2.3.3 Morquio Syndrome Treatment Market Challenges
2.3.4 Morquio Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Morquio Syndrome Treatment Players by Revenue
3.1.1 Global Top Morquio Syndrome Treatment Players by Revenue (2019-2024)
3.1.2 Global Morquio Syndrome Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Morquio Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Morquio Syndrome Treatment Revenue
3.4 Global Morquio Syndrome Treatment Market Concentration Ratio
3.4.1 Global Morquio Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Morquio Syndrome Treatment Revenue in 2023
3.5 Morquio Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Morquio Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Morquio Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Morquio Syndrome Treatment Breakdown Data by Type
4.1 Global Morquio Syndrome Treatment Historic Market Size by Type (2019-2024)
4.2 Global Morquio Syndrome Treatment Forecasted Market Size by Type (2025-2030)
5 Morquio Syndrome Treatment Breakdown Data by Application
5.1 Global Morquio Syndrome Treatment Historic Market Size by Application (2019-2024)
5.2 Global Morquio Syndrome Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Morquio Syndrome Treatment Market Size (2019-2030)
6.2 North America Morquio Syndrome Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Morquio Syndrome Treatment Market Size by Country (2019-2024)
6.4 North America Morquio Syndrome Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Morquio Syndrome Treatment Market Size (2019-2030)
7.2 Europe Morquio Syndrome Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Morquio Syndrome Treatment Market Size by Country (2019-2024)
7.4 Europe Morquio Syndrome Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Morquio Syndrome Treatment Market Size (2019-2030)
8.2 Asia-Pacific Morquio Syndrome Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Morquio Syndrome Treatment Market Size (2019-2030)
9.2 Latin America Morquio Syndrome Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Morquio Syndrome Treatment Market Size by Country (2019-2024)
9.4 Latin America Morquio Syndrome Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Morquio Syndrome Treatment Market Size (2019-2030)
10.2 Middle East & Africa Morquio Syndrome Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioMarin
11.1.1 BioMarin Company Detail
11.1.2 BioMarin Business Overview
11.1.3 BioMarin Morquio Syndrome Treatment Introduction
11.1.4 BioMarin Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.1.5 BioMarin Recent Development
11.2 Genzyme Corporation,
11.2.1 Genzyme Corporation, Company Detail
11.2.2 Genzyme Corporation, Business Overview
11.2.3 Genzyme Corporation, Morquio Syndrome Treatment Introduction
11.2.4 Genzyme Corporation, Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.2.5 Genzyme Corporation, Recent Development
11.3 Shire
11.3.1 Shire Company Detail
11.3.2 Shire Business Overview
11.3.3 Shire Morquio Syndrome Treatment Introduction
11.3.4 Shire Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.3.5 Shire Recent Development
11.4 JCR Pharmaceuticals
11.4.1 JCR Pharmaceuticals Company Detail
11.4.2 JCR Pharmaceuticals Business Overview
11.4.3 JCR Pharmaceuticals Morquio Syndrome Treatment Introduction
11.4.4 JCR Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.4.5 JCR Pharmaceuticals Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Morquio Syndrome Treatment Introduction
11.5.4 Sanofi Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Sangamo Therapeutics
11.6.1 Sangamo Therapeutics Company Detail
11.6.2 Sangamo Therapeutics Business Overview
11.6.3 Sangamo Therapeutics Morquio Syndrome Treatment Introduction
11.6.4 Sangamo Therapeutics Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.6.5 Sangamo Therapeutics Recent Development
11.7 Green Cross
11.7.1 Green Cross Company Detail
11.7.2 Green Cross Business Overview
11.7.3 Green Cross Morquio Syndrome Treatment Introduction
11.7.4 Green Cross Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.7.5 Green Cross Recent Development
11.8 Concert Pharmaceuticals
11.8.1 Concert Pharmaceuticals Company Detail
11.8.2 Concert Pharmaceuticals Business Overview
11.8.3 Concert Pharmaceuticals Morquio Syndrome Treatment Introduction
11.8.4 Concert Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.8.5 Concert Pharmaceuticals Recent Development
11.9 Alexion Pharmaceuticals
11.9.1 Alexion Pharmaceuticals Company Detail
11.9.2 Alexion Pharmaceuticals Business Overview
11.9.3 Alexion Pharmaceuticals Morquio Syndrome Treatment Introduction
11.9.4 Alexion Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.9.5 Alexion Pharmaceuticals Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Morquio Syndrome Treatment Introduction
11.10.4 Roche Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.10.5 Roche Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Morquio Syndrome Treatment Introduction
11.11.4 Pfizer Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Lupin
11.12.1 Lupin Company Detail
11.12.2 Lupin Business Overview
11.12.3 Lupin Morquio Syndrome Treatment Introduction
11.12.4 Lupin Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.12.5 Lupin Recent Development
11.13 Cambrex Corporation
11.13.1 Cambrex Corporation Company Detail
11.13.2 Cambrex Corporation Business Overview
11.13.3 Cambrex Corporation Morquio Syndrome Treatment Introduction
11.13.4 Cambrex Corporation Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.13.5 Cambrex Corporation Recent Development
11.14 Cipla
11.14.1 Cipla Company Detail
11.14.2 Cipla Business Overview
11.14.3 Cipla Morquio Syndrome Treatment Introduction
11.14.4 Cipla Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.14.5 Cipla Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Morquio Syndrome Treatment Introduction
11.15.4 Bayer Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.15.5 Bayer Recent Development
11.16 Daiichi Sankyo
11.16.1 Daiichi Sankyo Company Detail
11.16.2 Daiichi Sankyo Business Overview
11.16.3 Daiichi Sankyo Morquio Syndrome Treatment Introduction
11.16.4 Daiichi Sankyo Revenue in Morquio Syndrome Treatment Business (2019-2024)
11.16.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Morquio Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Morquio A
    Table 3. Key Players of Morquio B
    Table 4. Global Morquio Syndrome Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Morquio Syndrome Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Morquio Syndrome Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Morquio Syndrome Treatment Market Share by Region (2019-2024)
    Table 8. Global Morquio Syndrome Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Morquio Syndrome Treatment Market Share by Region (2025-2030)
    Table 10. Morquio Syndrome Treatment Market Trends
    Table 11. Morquio Syndrome Treatment Market Drivers
    Table 12. Morquio Syndrome Treatment Market Challenges
    Table 13. Morquio Syndrome Treatment Market Restraints
    Table 14. Global Morquio Syndrome Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Morquio Syndrome Treatment Market Share by Players (2019-2024)
    Table 16. Global Top Morquio Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Morquio Syndrome Treatment as of 2023)
    Table 17. Ranking of Global Top Morquio Syndrome Treatment Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Morquio Syndrome Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Morquio Syndrome Treatment Product Solution and Service
    Table 21. Date of Enter into Morquio Syndrome Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Morquio Syndrome Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Morquio Syndrome Treatment Revenue Market Share by Type (2019-2024)
    Table 25. Global Morquio Syndrome Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Morquio Syndrome Treatment Revenue Market Share by Type (2025-2030)
    Table 27. Global Morquio Syndrome Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Morquio Syndrome Treatment Revenue Market Share by Application (2019-2024)
    Table 29. Global Morquio Syndrome Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Morquio Syndrome Treatment Revenue Market Share by Application (2025-2030)
    Table 31. North America Morquio Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Morquio Syndrome Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Morquio Syndrome Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Morquio Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Morquio Syndrome Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Morquio Syndrome Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Morquio Syndrome Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Morquio Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Morquio Syndrome Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Morquio Syndrome Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Morquio Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. BioMarin Company Detail
    Table 47. BioMarin Business Overview
    Table 48. BioMarin Morquio Syndrome Treatment Product
    Table 49. BioMarin Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 50. BioMarin Recent Development
    Table 51. Genzyme Corporation, Company Detail
    Table 52. Genzyme Corporation, Business Overview
    Table 53. Genzyme Corporation, Morquio Syndrome Treatment Product
    Table 54. Genzyme Corporation, Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 55. Genzyme Corporation, Recent Development
    Table 56. Shire Company Detail
    Table 57. Shire Business Overview
    Table 58. Shire Morquio Syndrome Treatment Product
    Table 59. Shire Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 60. Shire Recent Development
    Table 61. JCR Pharmaceuticals Company Detail
    Table 62. JCR Pharmaceuticals Business Overview
    Table 63. JCR Pharmaceuticals Morquio Syndrome Treatment Product
    Table 64. JCR Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 65. JCR Pharmaceuticals Recent Development
    Table 66. Sanofi Company Detail
    Table 67. Sanofi Business Overview
    Table 68. Sanofi Morquio Syndrome Treatment Product
    Table 69. Sanofi Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 70. Sanofi Recent Development
    Table 71. Sangamo Therapeutics Company Detail
    Table 72. Sangamo Therapeutics Business Overview
    Table 73. Sangamo Therapeutics Morquio Syndrome Treatment Product
    Table 74. Sangamo Therapeutics Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 75. Sangamo Therapeutics Recent Development
    Table 76. Green Cross Company Detail
    Table 77. Green Cross Business Overview
    Table 78. Green Cross Morquio Syndrome Treatment Product
    Table 79. Green Cross Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 80. Green Cross Recent Development
    Table 81. Concert Pharmaceuticals Company Detail
    Table 82. Concert Pharmaceuticals Business Overview
    Table 83. Concert Pharmaceuticals Morquio Syndrome Treatment Product
    Table 84. Concert Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 85. Concert Pharmaceuticals Recent Development
    Table 86. Alexion Pharmaceuticals Company Detail
    Table 87. Alexion Pharmaceuticals Business Overview
    Table 88. Alexion Pharmaceuticals Morquio Syndrome Treatment Product
    Table 89. Alexion Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 90. Alexion Pharmaceuticals Recent Development
    Table 91. Roche Company Detail
    Table 92. Roche Business Overview
    Table 93. Roche Morquio Syndrome Treatment Product
    Table 94. Roche Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 95. Roche Recent Development
    Table 96. Pfizer Company Detail
    Table 97. Pfizer Business Overview
    Table 98. Pfizer Morquio Syndrome Treatment Product
    Table 99. Pfizer Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 100. Pfizer Recent Development
    Table 101. Lupin Company Detail
    Table 102. Lupin Business Overview
    Table 103. Lupin Morquio Syndrome Treatment Product
    Table 104. Lupin Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 105. Lupin Recent Development
    Table 106. Cambrex Corporation Company Detail
    Table 107. Cambrex Corporation Business Overview
    Table 108. Cambrex Corporation Morquio Syndrome Treatment Product
    Table 109. Cambrex Corporation Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 110. Cambrex Corporation Recent Development
    Table 111. Cipla Company Detail
    Table 112. Cipla Business Overview
    Table 113. Cipla Morquio Syndrome Treatment Product
    Table 114. Cipla Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 115. Cipla Recent Development
    Table 116. Bayer Company Detail
    Table 117. Bayer Business Overview
    Table 118. Bayer Morquio Syndrome Treatment Product
    Table 119. Bayer Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 120. Bayer Recent Development
    Table 121. Daiichi Sankyo Company Detail
    Table 122. Daiichi Sankyo Business Overview
    Table 123. Daiichi Sankyo Morquio Syndrome Treatment Product
    Table 124. Daiichi Sankyo Revenue in Morquio Syndrome Treatment Business (2019-2024) & (US$ Million)
    Table 125. Daiichi Sankyo Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Morquio Syndrome Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Morquio Syndrome Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Morquio A Features
    Figure 4. Morquio B Features
    Figure 5. Global Morquio Syndrome Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Morquio Syndrome Treatment Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Others Case Studies
    Figure 10. Morquio Syndrome Treatment Report Years Considered
    Figure 11. Global Morquio Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Morquio Syndrome Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Morquio Syndrome Treatment Market Share by Region: 2023 VS 2030
    Figure 14. Global Morquio Syndrome Treatment Market Share by Players in 2023
    Figure 15. Global Top Morquio Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Morquio Syndrome Treatment as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Morquio Syndrome Treatment Revenue in 2023
    Figure 17. North America Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Morquio Syndrome Treatment Market Share by Country (2019-2030)
    Figure 19. United States Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Morquio Syndrome Treatment Market Share by Country (2019-2030)
    Figure 23. Germany Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Morquio Syndrome Treatment Market Share by Region (2019-2030)
    Figure 31. China Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Morquio Syndrome Treatment Market Share by Country (2019-2030)
    Figure 39. Mexico Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Morquio Syndrome Treatment Market Share by Country (2019-2030)
    Figure 43. Turkey Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Morquio Syndrome Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. BioMarin Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 46. Genzyme Corporation, Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 47. Shire Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 48. JCR Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 49. Sanofi Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 50. Sangamo Therapeutics Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 51. Green Cross Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 52. Concert Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 53. Alexion Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 54. Roche Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 55. Pfizer Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 56. Lupin Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 57. Cambrex Corporation Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 58. Cipla Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 59. Bayer Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 60. Daiichi Sankyo Revenue Growth Rate in Morquio Syndrome Treatment Business (2019-2024)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Oculopharyngeal Muscular Dystrophy (OPMD) Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20M15561
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Genetic Disease Diagnosis Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11V13013
Wed Jun 12 00:00:00 UTC 2024

Add to Cart

Global Sickle Cell Anemia Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26Q12719
Fri May 24 00:00:00 UTC 2024

Add to Cart

Global Duchenne Muscular Dystrophy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-12K736
Fri May 24 00:00:00 UTC 2024

Add to Cart